Colorado recalls

Med Pride Triple Antibiotic Ointment packets were found to have manufacturing quality deficiencies during an FDA inspection. The affected lots do not meet federal quality standards, though no injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of the facility that produces Med Pride Hydrocortisone Cream 1%. These deviations from proper manufacturing standards affected multiple lots of the product currently still within their expiration dates.

The FDA found manufacturing quality control problems (CGMP deviations) during an inspection of the facility that makes Med Pride Hydrocortisone Cream 1%. Multiple lots of the product are affected. No injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of Med Pride 1% Clotrimazole Antifungal Cream. These deficiencies do not meet federal good manufacturing practice standards. About 5,755 tubes across multiple lots are affected.

The FDA found manufacturing deficiencies during an inspection of the facility that made Med Pride Bacitracin Zinc Ointment. This affects specific batches (Lot #022, 023, and 024) distributed nationwide.

The FDA found manufacturing quality control problems during an inspection of the facility that produced Med Pride Bacitracin Zinc Ointment. This ointment is used to help prevent infection in minor cuts and scrapes. The affected batches were distributed nationwide.

The FDA identified manufacturing quality control problems during an inspection of the facility that produces Med Pride Bacitracin Zinc Ointment. Certain lot numbers do not meet federal manufacturing standards for sterile wound-care products.

Dabur India Limited's Cura Hongos antifungal cream (clotrimazole 1%, 2oz tubes) was found to have manufacturing deficiencies during an FDA inspection. The affected product (Lot #0003) does not meet U.S. manufacturing standards. No injuries have been reported.

The FDA found manufacturing deficiencies during an inspection of the facility that made Rapidol Triple Antibiotic First Aid Ointment. The product does not meet federal manufacturing standards. About 84 tubes (Lot 0004) were distributed nationwide.

The FDA identified manufacturing deficiencies during an inspection of this triple antibiotic ointment product. The affected lot (0005) is still within its expiration date. No injuries have been reported.

Circle K triple antibiotic ointment tubes manufactured by Dabur India Limited have been recalled due to deficiencies found during an FDA inspection. The affected lots (0001 and 0005) do not meet current manufacturing standards for sterile products.

The FDA inspected the manufacturer of Lucky Super Soft First Aid Triple Antibiotic Ointment and found deficiencies in how the product was made and quality-controlled. The affected tubes are lot numbers 0002 and 0003, which are still within their expiration dates.

Dabur India Limited's Lucky Super Soft Antifungal Athlete's Foot Cream (Clotrimazole 1%, 1.5 oz tubes) is being recalled due to manufacturing deficiencies found during an FDA inspection. The affected lots (0001 and 0002) were distributed nationwide.

Inventia Healthcare Limited's chlorthalidone 25 mg tablets failed to meet dissolution specifications, meaning the tablets may not break down properly in the body and deliver the full dose. This affects 100-tablet and 1000-tablet bottles distributed nationwide. No injuries have been reported.

Sandoz is recalling one lot of Focalin XR (dexmethylphenidate HCl) 5 mg extended-release capsules because some bottles have incorrect or missing lot numbers and expiration dates on the label. The affected lot (VA0099422) was distributed nationwide. This is a labeling issue only; the medication itself has not been found to be unsafe.

Safco SensiCaine-Ultra topical anesthetic gel bottles may have incomplete seals, which could allow the product to leak or become contaminated. This affects 150 units distributed nationwide. No injuries have been reported.

PureLife topical anesthetic gel (benzocaine 20%, 1 oz) may contain bottles with incomplete seals. This could allow the product to leak or become contaminated. About 450 units were distributed nationwide.

Dental City topical anesthetic gel (benzocaine 20%, strawberry flavor) may contain bottles with incomplete seals. This defect could allow the product to leak or become contaminated. The recall affects 450 units distributed nationwide.

Burkhart topical anesthetic gel (benzocaine 20%, strawberry flavor) may contain bottles with incomplete seals, which could allow the product to leak or become contaminated. About 150 units with expiration date 04/15/2029 are affected nationwide.

DHP Topical Anesthetic Gel (Benzocaine 20%, Strawberry Flavor) may contain bottles with incomplete seals that could compromise the integrity of the product. About 150 units with lot number BNZ-001921 and expiration date April 15, 2029 were distributed nationwide.

Quala Dental Products topical anesthetic gel (20% benzocaine, strawberry flavor, 1 oz bottles) may have incomplete seals on some bottles. This could allow the product to leak or become contaminated. The recall affects 150 units distributed nationwide.

Pearson Quality Topical Anesthetic Gel (20% benzocaine, mint flavor) may contain bottles with incomplete seals. The defective containers could allow the product to leak or become contaminated. About 900 units are affected nationwide.

Par Health USA's buprenorphine HCl injection (0.3 mg/mL) has been found to contain crystallization identified as buprenorphine free base in certain lots. This affects vials distributed nationwide. The FDA has classified this as a Class II recall.

Ajanta Pharma USA Inc. distributed bottles labeled as Aripiprazole 30 mg that actually contained Voriconazole 50 mg, a different medication used to treat fungal infections. This mix-up affected 6,143 bottles (Lot PA00805, expiring 01/31/2029) distributed nationwide. The error was discovered and reported to the FDA.

IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.

VistaPharm's Kerr Insta-Char activated charcoal product did not meet the required Over-the-Counter (OTC) Monograph standards set by the FDA. The affected product is a 240 mL bottle containing 50 grams of activated charcoal in a sorbitol base with cherry flavor (Lot #AH001, expiring 8/31/2026).

VistaPharm's Kerr Insta-Char activated charcoal suspension did not meet the standards required for over-the-counter products. The product was distributed nationwide, and affected lots should not be used.

VistaPharm's Kerr Insta-Char activated charcoal product did not meet the required OTC Monograph M023 standards set by the FDA. The affected product is a 240 ml bottle containing 50 grams of activated charcoal with cherry flavor (Lot #AE001, expiring 5/31/2026) distributed nationwide.

VistaPharm's Kerr Insta-Char activated charcoal product failed to meet required Over-the-Counter (OTC) monograph standards. The product may not perform as intended or meet quality requirements for safety and effectiveness.

Glenmark Pharmaceuticals is recalling specific lots of Alyacen 7/7/7 (a birth control pill) because testing found higher-than-allowed impurity levels in the tablets. The affected lots were distributed nationwide. No injuries have been reported.